According to a recent report presented by Inova Health at the American College of Gastroenterology, patients with a high baseline obestatin, may be more attractive candidates for Roux-en-Y bypass surgery. Researchers collected samples from 35 patients and found that those with high levels of obestatin showed a significant increase in weight loss the first three months following surgery, and maintained a strong rate of weight loss even 24 months after surgery.

Click here to read more.